Bell Investment Advisors’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-200
Closed -$19.7K 1880
2025
Q2
$19.7K Buy
200
+44
+28% +$4.16K ﹤0.01% 428
2025
Q1
$14.5K Buy
156
+31
+25% +$2.86K ﹤0.01% 479
2024
Q4
$11.3K Buy
125
+28
+29% +$2.57K ﹤0.01% 556
2024
Q3
$9.36K Sell
97
-7
-7% -$683 ﹤0.01% 652
2024
Q2
$9.55K Buy
104
+26
+33% +$2.41K ﹤0.01% 630
2024
Q1
$7.19K Hold
78
﹤0.01% 725
2023
Q4
$7.42K Buy
78
+31
+66% +$2.9K ﹤0.01% 679
2023
Q3
$4.39K Sell
47
-7
-13% -$647 ﹤0.01% 875
2023
Q2
$4.94K Buy
54
+24
+80% +$1.97K ﹤0.01% 832
2023
Q1
$2.21K Buy
30
+9
+43% +$779 ﹤0.01% 1211
2022
Q4
$1.75K Buy
21
+10
+91% +$902 ﹤0.01% 1358
2022
Q3
$1K Sell
11
-8
-42% -$954 ﹤0.01% 1301
2022
Q2
$2K Buy
+19
New +$2.43K ﹤0.01% 1082
2021
Q4
$2K Buy
14
+5
+56% +$804 ﹤0.01% 1085
2021
Q3
$1K Buy
+9
New +$1.87K ﹤0.01% 1246

Other funds holding AMED

Bell Investment Advisors's AMED Position: Q3 2025 in Review

Bell Investment Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 200 shares — an estimated $19.7K sold.

Bell Investment Advisors first reported a position in AMED in Q3 2021 and held it in 15 quarters. The position peaked at $19.7K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Bell Investment Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Bell Investment Advisors sold 200 Amedisys shares in Q3 2025, an estimated $19.7K.
  • Bell Investment Advisors first reported a position in Amedisys in Q3 2021 and held it in 15 quarters.
  • Bell Investment Advisors's Amedisys position peaked at $19.7K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Bell Investment Advisors's 13F filing for Q3 2025, filed 21 Nov 2025.